282 related articles for article (PubMed ID: 28674873)
1. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.
Greco V; Piras C; Pieroni L; Urbani A
Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873
[TBL] [Abstract][Full Text] [Related]
2. Pre- and Post-analytical Factors in Biomarker Discovery.
Klont F; Horvatovich P; Govorukhina N; Bischoff R
Methods Mol Biol; 2019; 1959():1-22. PubMed ID: 30852812
[TBL] [Abstract][Full Text] [Related]
3. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.
Pieragostino D; Petrucci F; Del Boccio P; Mantini D; Lugaresi A; Tiberio S; Onofrj M; Gambi D; Sacchetta P; Di Ilio C; Federici G; Urbani A
J Proteomics; 2010 Jan; 73(3):579-92. PubMed ID: 19666151
[TBL] [Abstract][Full Text] [Related]
4. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation.
Bhosale SD; Moulder R; Kouvonen P; Lahesmaa R; Goodlett DR
Methods Mol Biol; 2017; 1619():451-466. PubMed ID: 28674903
[TBL] [Abstract][Full Text] [Related]
5. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
6. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
[TBL] [Abstract][Full Text] [Related]
7. Plasma Proteome Profiling to detect and avoid sample-related biases in biomarker studies.
Geyer PE; Voytik E; Treit PV; Doll S; Kleinhempel A; Niu L; Müller JB; Buchholtz ML; Bader JM; Teupser D; Holdt LM; Mann M
EMBO Mol Med; 2019 Nov; 11(11):e10427. PubMed ID: 31566909
[TBL] [Abstract][Full Text] [Related]
8. Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics.
Shen X; Hu Q; Li J; Wang J; Qu J
J Proteome Res; 2015 Oct; 14(10):4147-57. PubMed ID: 26051676
[TBL] [Abstract][Full Text] [Related]
9. Identifying Biomarker Candidates in the Blood Plasma or Serum Proteome.
Garcia S; Silva-Costa LC; Reis-de-Oliveira G; Guest PC; Baldasso PA; Cassoli JS; Martins-de-Souza D
Adv Exp Med Biol; 2017; 974():193-203. PubMed ID: 28353236
[TBL] [Abstract][Full Text] [Related]
10. Plasma/Serum Proteomics based on Mass Spectrometry.
Zhu Y
Protein Pept Lett; 2024; 31(3):192-208. PubMed ID: 38869039
[TBL] [Abstract][Full Text] [Related]
11. Effects of differences in pre-analytical processing on blood protein profiles determined with SWATH-MS.
Nambu M; Nishiumi S; Kobayashi T; Masuda T; Ito S; Yoshida M; Ohtsuki S
J Proteomics; 2020 Jul; 223():103824. PubMed ID: 32445911
[TBL] [Abstract][Full Text] [Related]
12. Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.
Percy AJ; Parker CE; Borchers CH
Bioanalysis; 2013 Nov; 5(22):2837-56. PubMed ID: 24256362
[TBL] [Abstract][Full Text] [Related]
13. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology tools: proteomics techniques in biomarker discovery.
Lottspeich F; Kellermann J; Keidel EM
Scand J Clin Lab Invest Suppl; 2010; 242():19-22. PubMed ID: 20515271
[TBL] [Abstract][Full Text] [Related]
15. Systematic Evaluation of the Use of Human Plasma and Serum for Mass-Spectrometry-Based Shotgun Proteomics.
Lan J; Núñez Galindo A; Doecke J; Fowler C; Martins RN; Rainey-Smith SR; Cominetti O; Dayon L
J Proteome Res; 2018 Apr; 17(4):1426-1435. PubMed ID: 29451788
[TBL] [Abstract][Full Text] [Related]
16. Plasma Biomarker Identification and Quantification by Microparticle Proteomics.
Harel M; Geiger T
Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry.
Cominetti O; Núñez Galindo A; Corthésy J; Oller Moreno S; Irincheeva I; Valsesia A; Astrup A; Saris WH; Hager J; Kussmann M; Dayon L
J Proteome Res; 2016 Feb; 15(2):389-99. PubMed ID: 26620284
[TBL] [Abstract][Full Text] [Related]
18. High-Throughput Plasma Proteomic Profiling.
Soni RK
Methods Mol Biol; 2022; 2546():411-420. PubMed ID: 36127608
[TBL] [Abstract][Full Text] [Related]
19. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
Dittrich J; Ceglarek U
Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
[TBL] [Abstract][Full Text] [Related]
20. Serum and plasma proteomics and its possible use as detector and predictor of radiation diseases.
Guipaud O
Adv Exp Med Biol; 2013; 990():61-86. PubMed ID: 23378003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
